Liu SJ. Inhibition of L-type Ca 2ϩ channel current and negative inotropy induced by arachidonic acid in adult rat ventricular myocytes. Am J Physiol Cell Physiol 293: C1594-C1604, 2007. First published September 5, 2007; doi:10.1152/ajpcell.00284.2007.-We have previously shown an increase in arachidonic acid (AA) release in response to proinflammatory cytokines in adult rat ventricular myocytes (ARVM). AA is known to alter channel activities; however, its effects on cardiac L-type Ca 2ϩ channel current (ICa,L) and excitationcontraction coupling remain unclear. The present study examined effects of AA on I Ca,L, using the whole cell patch-clamp technique, and on cell shortening (CS) and the Ca 2ϩ transient of ARVM. ICa,L was monitored in myocytes held at Ϫ70 mV and internally equilibrated and externally perfused with Na ϩ -and K ϩ -free solutions. Exposure to AA caused a voltage-dependent block of I Ca,L concentration dependently (IC 50 8.5 M). The AA-induced inhibition of I Ca,L is consistent with its hyperpolarizing shift in the voltagedependent properties and reduction in maximum slope conductance. In the presence of AA, BSA completely blocked the AA-induced suppression of I Ca,L and CS. Intracellular load with AA had no effect on the current density but caused a small depolarizing shift in the I Ca,L activation curve, suggesting a site-specific action of AA. Moreover, intracellular AA had no effect on the extracellular AA-induced decrease in I Ca,L. Pretreatment with indomethacin, an inhibitor of cyclooxygenase, or addition of nordihydroguaiaretic acid, an inhibitor of lipoxygenase, had no effect on AA-induced changes in I Ca,L. Furthermore, AA suppressed CS and Ca 2ϩ transients of intact ARVM with no significant effect on SR function and myofilament Ca 2ϩ sensitivity. Therefore, these results suggest that AA inhibits contractile function of ARVM, primarily due to its direct inhibition of I Ca,L at an extracellular site. excitation-contraction coupling; cell shortening; contractility; Ca 2ϩ transient ARACHIDONIC ACID (AA), an omega-6 (-6) polyunsaturated fatty acid, is a major constituent of membrane phospholipids and an important precursor in production of eicosanoids. AA is liberated from membrane phospholipids primarily via activation of phospholipases A 2 (PLA 2 ) (12). We (33, 37) also previously reported that AA is rapidly released from isolated single adult rat ventricular myocytes (ARVM) via activation of different isoforms of PLA 2 in response to proinflammatory cytokines, interleukin-1 (IL-1) (33, 37), and tumor necrosis factor-␣ (TNF-␣) (33). After being released, AA acts on target cells in an autocrine and/or paracrine fashion and is metabolized in cytosol to various eicosanoid products that mediate a variety of cellular responses under pathophysiological conditions including heart disease and atherosclerosis (11). Moreover, AA itself is a bioactive molecule (7) and has been shown to alter ion channel activities in cardiac myocytes (25,41,53) and in other cell types (16,17,35,44,46,50 (49) and a...